Bone Biologics Corporation

NasdaqCM:BBLG Stock Report

Mkt Cap: US$1.8m

Bone Biologics Future Growth

Future criteria checks 0/6

Bone Biologics's earnings are forecast to decline at 30.9% per annum. EPS is expected to grow by 4.9% per annum.

Key information

-30.9%

Earnings growth rate

4.9%

EPS growth rate

Biotechs earnings growth19.8%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

Low

Last updated15 Nov 2023

Recent future growth updates

Recent updates

Companies Like Bone Biologics (NASDAQ:BBLG) Are In A Position To Invest In Growth

Jun 07
Companies Like Bone Biologics (NASDAQ:BBLG) Are In A Position To Invest In Growth

Bone Biologics prices $5.1M underwritten public offering

Oct 07

We're Not Very Worried About Bone Biologics' (NASDAQ:BBLG) Cash Burn Rate

Mar 18
We're Not Very Worried About Bone Biologics' (NASDAQ:BBLG) Cash Burn Rate

Earnings and Revenue Growth Forecasts

NasdaqCM:BBLG - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2025N/A-14N/AN/A1
12/31/2024N/A-13N/AN/A1
12/31/2023N/AN/AN/AN/A1
9/30/2023N/A-7-9-9N/A
6/30/2023N/A-6-7-7N/A
3/31/2023N/A-5-4-4N/A
12/31/2022N/A-1-4-4N/A
9/30/2022N/A-3-2-2N/A
6/30/2022N/A-2-2-2N/A
3/31/2022N/A-2-2-2N/A
12/31/2021N/A-2-1-1N/A
9/30/2021N/A-2-1-1N/A
6/30/2021N/A-2-1-1N/A
3/31/2021N/A-200N/A
12/31/2020N/A-200N/A
9/30/2020N/A-2-1-1N/A
6/30/2020N/A-2-1-1N/A
3/31/2020N/A-3-2-2N/A
12/31/2019N/A-3-3-3N/A
9/30/2019N/A-4-4-4N/A
6/30/2019N/A-4-5-5N/A
3/31/2019N/A-4-4-4N/A
12/31/2018N/A-4-4-4N/A
9/30/2018N/A-6-4-4N/A
6/30/2018N/A-8-3-3N/A
3/31/2018N/A-6-3-3N/A
12/31/2017N/A-7-3-3N/A
9/30/2017N/A-14-4-4N/A
6/30/2017N/A-16N/A-5N/A
3/31/2017N/A-22N/A-6N/A
12/31/2016N/A-26N/A-7N/A
9/30/2016N/A-24N/A-7N/A
6/30/2016N/A-23N/A-7N/A
3/31/2016N/A-19N/A-6N/A
12/31/2015N/A-14N/A-4N/A
9/30/2015N/A-7N/A-4N/A
6/30/2015N/A-6N/A-4N/A
3/31/2015N/A-6N/A-3N/A
12/31/2014N/A-4N/A-3N/A
9/30/2014N/A-4N/A-1N/A
6/30/2014N/A-1N/A0N/A
3/31/2014N/A-1N/A0N/A
12/31/2013N/A-1N/A-1N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: BBLG is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: BBLG is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: BBLG is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: Insufficient data to determine if BBLG's revenue is forecast to grow faster than the US market.

High Growth Revenue: BBLG is forecast to have no revenue next year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if BBLG's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Price7D1Y
Mkt CapP/EGrowth
Price7D1Y
Mkt CapP/EGrowth
Price7D1Y
Mkt CapP/EGrowth
Price7D1Y
Mkt CapP/EGrowth